ArticleCancer research and treatment2020
Socioeconomic Burden of Cancer in Korea from 2011 to 2015.
Article in Cancer research and treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.Clinical and molecular hepatology · 2022Guideline
- The cost of oral cancer: A systematic review.PloS one · 2022Pooled it
- What drives patients' preferences for cancer care in South Korea's capital area? A study on preferences concerning cancer care facilities.BMC health services research · 2026Article
- National-level estimation of long-term economic burden for lung cancer patients in China.Frontiers in public health · 2026Article
- From Fear to Adaptation: The Journey of Patients with Liver Cancer Living with the Fear of Cancer Recurrence.Current oncology (Toronto, Ont.) · 2025Article
- The delayed cancer treatment and economic inequality in Korea: results of common cancers by the time-to-surgery.Epidemiology and health · 2025Article
- Trends in Cancer-Screening Rates in Korea: Findings from the National Cancer Screening Survey, 2004-2023.Cancer research and treatment · 2025Article
- Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024Article
- High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study.Journal of Korean medical science · 2024Article
- Economic Burden of Healthcare Services on Cancer Survivors in Bangladesh.Cancer reports (Hoboken, N.J.) · 2024Article
- Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma.Yonsei medical journal · 2024Article
- Gastric and colorectal cancer incidence attributable to dietary factors in Korea.Journal of gastrointestinal oncology · 2024Article
- Review
- Economic burden of cancer attributable to modifiable risk factors in Japan.Global health & medicine · 2023Article
- The effects of hospice care on healthcare expenditure among cancer patients.BMC health services research · 2023Article
- Operational Definitions of Colorectal Cancer in the Korean National Health Insurance Database.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2023Review
- Incidence of dysphagia requiring medical attention in various types of cancers: A nationwide population-based cohort study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.Journal of liver cancer · 2023Review
- 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.Korean journal of radiology · 2022Review
- The population-level economic burden of liver cancer in China, 2019-2030: prevalence-based estimations from a societal perspective.Cost effectiveness and resource allocation : C/E · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThough the socioeconomic burden of cancer on patients is increasing in South Korea, there is little research regarding the type of cancer that incurs the highest costs. This study analyzed the socioeconomic burden on cancer patients from 2011 to 2015 according to sex and age. MATERIALS AND
methodsA prevalence-based approach was applied utilizing claim data of the National Health Insurance Service in Korea to estimate the socioeconomic burden of cancer on patients. Patients who received treatment for cancer from 2011 to 2015 were the study subjects. The total socioeconomic burden of their disease and treatment was divided into direct and indirect costs.
resultsThere was an increase of 50.7% for 5 years, from 821,525 to 1,237,739 cancer patients. The cancer costs for men and women increased $8,268.4 million to $9,469.7 million and $3,626.5 million to $4,475.6 million, respectively. Furthermore, the 50-59-year-old age group accounted for a large portion of the total disease cost. Liver, lung, stomach, and colorectal cancers created the heaviest economic burdens on patients.
conclusionOverall, this study indicates new policies for cancer prevention, early detection, and post-cancer treatment management are necessary to help limit the costs associatedwith cancer, especially in the elderly, and provides a foundation for establishing cancer-related health care policies, particularly by defining those cancers with heavier disease burdens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.